Stay updated on Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Sign up to get notified when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.

Latest updates to the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Type 1 diabetes extension-study record is available, with details on the insulin glargine comparison, participant eligibility, study outcomes, and 81 study locations. The record also includes study documents and results-history information.SummaryDifference79%

- Check20 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH notice about updated terminology during the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision marker changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.3%

- Check41 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.3%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden message instead of the study content, indicating restricted access to the record and its information.SummaryDifference17%

Stay in the know with updates to Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.